A common genetic deficiency empowers glioblastoma to broadcast a molecular message to the wrong type of immune cell, summoning macrophages that protect and nurture the brain tumor instead of attacking it, researchers at The ...
Jun 10, 2019
0
75
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the ...
Jul 4, 2012
0
0
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Jul 29, 2021
0
249
A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins ...
Aug 6, 2024
0
45
Rapidly increasing cancer incidence and mortality worldwide have raised great challenges for the currently available anticancer options, which warrants the development of new therapeutic modalities based on novel antitumor ...
Apr 29, 2020
0
1
A critical new pathway to treating an aggressive brain tumor might be found in the complex diversity within the tumor tissue, according to a new paper by scientists from the Hackensack Meridian Center for Discovery and Innovation ...
Oct 31, 2022
0
139
A molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients, according to a study published in the journal Cell Genomics.
Sep 29, 2023
0
67
Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.
Dec 12, 2023
0
47
A natural substance found in the surrounding tissue of a tumor may be a promising weapon to stop triple negative breast cancer from metastasizing.
Sep 19, 2012
0
0
Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer ...
Jun 9, 2011
0
0
